BRISTOL-MYERS SQUIBB COMPANY Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax of $0 for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-10-25.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax · last filed 2018-10-25
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), derivatives qualifying as hedges, tax for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), derivatives qualifying as hedges, tax for the quarter ending 2018-06-30 was -$11.00M, a 178.57% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), derivatives qualifying as hedges, tax for the quarter ending 2018-03-31 was -$1.00M, a 109.09% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), derivatives qualifying as hedges, tax for the quarter ending 2017-12-31 was -$6.00M.
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), derivatives qualifying as hedges, tax for fiscal 2017 was $25.00M.
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), derivatives qualifying as hedges, tax for fiscal 2016 was -$3.00M, a 115.00% decline from fiscal 2015.
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), derivatives qualifying as hedges, tax for fiscal 2015 was $20.00M.
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), derivatives qualifying as hedges, tax for fiscal 2014 was -$29.00M, a 680.00% decline from fiscal 2013.
| Period end | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax 3 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax 3 month as first filed | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax 6 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax 9 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax 9 month as first filed | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax 12 month |
|---|---|---|---|---|---|---|
| 2018-09-30 | $0.00 10-Q · filed 2018-10-25 | -$11.00M derived: sum of 2 quarters · filed 2018-10-25 | -$12.00M 10-Q · filed 2018-10-25 | -$18.00M derived: sum of 4 quarters · filed 2018-10-25 | ||
| 2018-06-30 | -$11.00M 10-Q · filed 2018-07-26 | -$12.00M 10-Q · filed 2018-07-26 | -$18.00M derived: sum of 3 quarters · filed 2018-07-26 | -$12.00M derived: sum of 4 quarters · filed 2018-10-25 | ||
| 2018-03-31 | -$1.00M 10-Q · filed 2018-04-26 | -$7.00M derived: sum of 2 quarters · filed 2018-04-26 | -$1.00M derived: sum of 3 quarters · filed 2018-10-25 | $13.00M derived: sum of 4 quarters · filed 2018-10-25 | ||
| 2017-12-31 | -$6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $0.00 derived: sum of 2 quarters · filed 2018-10-25 | $14.00M derived: sum of 3 quarters · filed 2018-10-25 | $25.00M 10-K · filed 2018-02-13 | ||
| 2017-09-30 | $6.00M 10-Q · filed 2018-10-25 | $20.00M derived: sum of 2 quarters · filed 2018-10-25 | $31.00M 10-Q · filed 2018-10-25 | -$33.00M derived: sum of 4 quarters · filed 2018-10-25 | ||
| 2017-06-30 | $14.00M 10-Q · filed 2018-07-26 | $25.00M 10-Q · filed 2018-07-26 | -$39.00M derived: sum of 3 quarters · filed 2018-07-26 | -$42.00M derived: sum of 4 quarters · filed 2018-07-26 | ||
| 2017-03-31 | $11.00M 10-Q · filed 2018-04-26 | -$53.00M derived: sum of 2 quarters · filed 2018-04-26 | -$56.00M derived: sum of 3 quarters · filed 2018-04-26 | -$36.00M derived: sum of 4 quarters · filed 2018-04-26 | ||
| 2016-12-31 | -$64.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | -$67.00M derived: sum of 2 quarters · filed 2018-02-13 | -$47.00M derived: sum of 3 quarters · filed 2018-02-13 | -$3.00M 10-K · filed 2018-02-13 | ||
| 2016-09-30 | -$3.00M 10-Q · filed 2017-10-26 | $17.00M derived: sum of 2 quarters · filed 2017-10-26 | $61.00M 10-Q · filed 2017-10-26 | $64.00M derived: sum of 4 quarters · filed 2018-02-13 | ||
| 2016-06-30 | $20.00M 10-Q · filed 2017-07-27 | $64.00M 10-Q · filed 2017-07-27 | $67.00M derived: sum of 3 quarters · filed 2018-02-13 | $94.00M derived: sum of 4 quarters · filed 2018-02-13 | ||
| 2016-03-31 | $44.00M 10-Q · filed 2017-04-27 | $47.00M derived: sum of 2 quarters · filed 2018-02-13 | $74.00M derived: sum of 3 quarters · filed 2018-02-13 | $66.00M derived: sum of 4 quarters · filed 2018-02-13 | ||
| 2015-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $30.00M derived: sum of 2 quarters · filed 2018-02-13 | $22.00M derived: sum of 3 quarters · filed 2018-02-13 | $20.00M 10-K · filed 2018-02-13 | ||
| 2015-09-30 | $27.00M 10-Q · filed 2016-10-27 | $19.00M derived: sum of 2 quarters · filed 2016-10-27 | $17.00M 10-Q · filed 2016-10-27 | $8.00M derived: sum of 4 quarters · filed 2017-02-21 | ||
| 2015-06-30 | -$8.00M 10-Q · filed 2016-07-28 | -$10.00M 10-Q · filed 2016-07-28 | -$19.00M derived: sum of 3 quarters · filed 2017-02-21 | -$45.00M derived: sum of 4 quarters · filed 2017-02-21 | ||
| 2015-03-31 | -$2.00M 10-Q · filed 2016-04-28 | -$11.00M derived: sum of 2 quarters · filed 2017-02-21 | -$37.00M derived: sum of 3 quarters · filed 2017-02-21 | -$35.00M derived: sum of 4 quarters · filed 2017-02-21 | ||
| 2014-12-31 | -$9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | -$35.00M derived: sum of 2 quarters · filed 2017-02-21 | -$33.00M derived: sum of 3 quarters · filed 2017-02-21 | -$29.00M 10-K · filed 2017-02-21 | ||
| 2014-09-30 | -$26.00M 10-Q · filed 2015-10-27 | -$24.00M derived: sum of 2 quarters · filed 2015-10-27 | -$20.00M 10-Q · filed 2015-10-27 | -$9.00M derived: sum of 4 quarters · filed 2016-02-12 | ||
| 2014-06-30 | $2.00M 10-Q · filed 2015-07-23 | $6.00M 10-Q · filed 2015-07-23 | $17.00M derived: sum of 3 quarters · filed 2016-02-12 | $28.00M derived: sum of 4 quarters · filed 2016-02-12 | ||
| 2014-03-31 | $4.00M 10-Q · filed 2015-04-28 | $15.00M derived: sum of 2 quarters · filed 2016-02-12 | $26.00M derived: sum of 3 quarters · filed 2016-02-12 | $27.00M derived: sum of 4 quarters · filed 2016-02-12 | ||
| 2013-12-31 | $11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $22.00M derived: sum of 2 quarters · filed 2016-02-12 | $23.00M derived: sum of 3 quarters · filed 2016-02-12 | $5.00M 10-K · filed 2016-02-12 | ||
| 2013-09-30 | $11.00M 10-Q · filed 2014-10-24 | $12.00M derived: sum of 2 quarters · filed 2014-10-24 | -$6.00M 10-Q · filed 2014-10-24 | -$10.00M derived: sum of 4 quarters · filed 2015-02-13 | ||
| 2013-06-30 | $1.00M 10-Q · filed 2014-07-24 | -$17.00M 10-Q · filed 2014-07-24 | -$21.00M derived: sum of 3 quarters · filed 2015-02-13 | -$3.00M derived: sum of 4 quarters · filed 2015-02-13 | ||
| 2013-03-31 | -$18.00M 10-Q · filed 2014-04-29 | -$22.00M derived: sum of 2 quarters · filed 2015-02-13 | -$4.00M derived: sum of 3 quarters · filed 2015-02-13 | -$8.00M derived: sum of 4 quarters · filed 2015-02-13 | ||
| 2012-12-31 | -$4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | $14.00M derived: sum of 2 quarters · filed 2015-02-13 | $10.00M derived: sum of 3 quarters · filed 2015-02-13 | $3.00M 10-K · filed 2015-02-13 | ||
| 2012-09-30 | $18.00M 10-Q · filed 2013-10-23 | $9.00M 10-Q · filed 2012-10-24 | $14.00M derived: sum of 2 quarters · filed 2013-10-23 | $7.00M 10-Q · filed 2013-10-23 | -$8.00M 10-Q · filed 2012-10-24 | -$20.00M derived: sum of 4 quarters · filed 2014-02-14 |
| 2012-06-30 | -$4.00M 10-Q · filed 2013-07-25 | -$11.00M 10-Q · filed 2013-07-25 | -$38.00M derived: sum of 3 quarters · filed 2014-02-14 | -$61.00M derived: sum of 4 quarters · filed 2014-02-14 | ||
| 2012-03-31 | -$7.00M 10-Q · filed 2013-04-25 | -$34.00M derived: sum of 2 quarters · filed 2014-02-14 | -$57.00M derived: sum of 3 quarters · filed 2014-02-14 | |||
| 2011-12-31 | -$27.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-14 | -$50.00M derived: sum of 2 quarters · filed 2014-02-14 | -$24.00M 10-K · filed 2014-02-14 | |||
| 2011-09-30 | -$23.00M 10-Q · filed 2012-10-24 | $3.00M 10-Q · filed 2012-10-24 | ||||
| 2010-12-31 | $2.00M 10-K · filed 2013-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |